BioRestorative Therapies Announces Notice of Allowance for New Patent Application in Japan and Expansion of ThermoStem® IP Portfolio
February 02, 2022 08:00 ET
|
BioRestorative Therapies, Inc
Notice of Allowance Grants Protection for Generating Implantable Three-Dimensional Scaffolds MELVILLE, N.Y., Feb. 02, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or...
BioRestorative Therapies to Present at H.C. Wainwright BioConnect Virtual Conference
January 06, 2022 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
December 21, 2021 16:01 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...
BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program
December 02, 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Dec. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...
BioRestorative Therapies Enters into Letter of Intent with PRC Clinical
November 19, 2021 06:00 ET
|
BioRestorative Therapies, Inc
PRC Clinical to Provide Start-up CRO Services for BRTX-100 Phase 2 Clinical Trial MELVILLE, N.Y., Nov. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or...
BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
October 26, 2021 08:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
September 02, 2021 09:00 ET
|
BioRestorative Therapies, Inc
Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use MELVILLE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 09, 2021 11:58 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
May 10, 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...